NGM Biopharmaceuticals Inc. Stock News

Intercept is ahead of a potential FDA approval that could lead to a market opportunity worth billions of dollars. However, the stock is sharply down this year a

SOUTH SAN FRANCISCO, Calif., May 29, 2020 -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a biotechnology company focused on developing transformative therapeutics for patients,.

In her role as CFO, which will take effect on July 13, 2020, Ms. Nolan Mangini will oversee finance, business development and investor relations at NGM. “Siobhan’s deep financial expertise, coupl

NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 3.45% and 22.33%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

-- Initiated Phase 2b ALPINE 4 clinical study of aldafermin (formerly NGM282) in non-alcoholic steatohepatitis (NASH) patients with compensated cirrhosis (F4 fibrosis) -- --.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Acceleron Pharma Inc (NASDAQ...

The virtual Annual Meeting is expected to provide stockholders with the same rights and opportunities to participate as they would have at an in-person meeting. The previously announced date and time

Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Im

NGM is a unique business model with a lead program with exciting phase 2 data in NASH and a de-risked pipeline buffered by Merck. NGM is led by an experienced a

Final earnings conference call transcript of Viking Therapeutics Inc - VKTX stock

Market watchers are looking to the insiders, hoping insights from their activity can steer them towards returns from these stocks to buy.

Tables of the top insider purchases and sales filed with the SEC on 4/9/20, based on dollar value. Dollar values often do not equate with significance when it c

Akero’s FGF21 analog yields 63 percent to 72 percent relative hepatic fat reduction in Phase 2a study; the company awaits biopsy data hoping to see a

The market gained almost 9% in the week of 2 April until 8 April. Investors with much cash on hand can keep cautiously buying high-quality stocks. Mimicking ins

Tables of the top insider purchases and sales filed with the SEC on 4/7/20, based on dollar value. Dollar values often do not equate with significance when it c